相关实验视频

Updated: Jun 23, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

APR-246作为对基于α颗粒的放射治疗治疗的突变p53癌症的放射敏感化策略

Or Michaeli¹, Ishai Luz¹, Maayan Vatarescu^1,2

¹The Shraga Segal Department of Microbiology, Immunology & Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.

Cell death & disease

|June 18, 2024

概括

这项研究表明,将α粒子辐射疗法与APR-246结合起来,可以有效治疗突变p53癌症. 这种方法增强了癌细胞的死亡,减少了瘤的生长,为难以治疗的瘤提供了一个有希望的新策略.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
癌症遗传学癌症遗传学

背景情况:

放射治疗 (RT) 是癌症治疗的基石,但有效向瘤仍然存在挑战.
高线性能量转移 (高-LET) 辐射,像α粒子一样,诱导强大的DNA损伤,但范围有限.
人类癌症中TP53瘤抑制基因的突变很常见,通常会对传统疗法产生抗性.

研究的目的:

为了研究使用Radium-224 (224Ra) 与APR-246,一种p53活性化化合物,结合基于α粒子的RT的疗效.
在结直肠癌 (CRC) 和胰腺管腺癌 (PDAC) 的临床前模型中评估这种组合疗法,具有突变p53.
评估对癌细胞存活,瘤生长和细胞死亡的空间分布的影响.

主要方法:

利用了CRC和PDAC携带突变p53.3的细胞模型和瘤异种移植.
进行阿尔法粒子辐射和全身APR-246治疗,单独或组合.
评估了细胞存活率,瘤生长抑制,瘤根除率,α-emitter分布和亡模式.

主要成果:

突变的p53癌细胞在体外和体内表现出对α粒子的放射敏感性.
治疗APR-246显著提高了对α粒子RT的敏感性.
组合疗法导致瘤生长减少和瘤根除增加,观察到增强的细胞死亡.

结论:

通过APR-246将α粒子RT与p53恢复结合起来,是治疗突变p53癌症的一个有希望的策略.
这种方法触发了显著的细胞死亡,并在临床前模型中改善了治疗结果.
需要进一步的研究,以将这些发现转化为对p53突变瘤患者的临床应用.

更多相关视频

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...